Research Article
Identification and Determination of Impurities in a New Therapeutic Agent for Fatty Liver Disease
Table 2
Summary of the validation report of the proposed methods.
| Parameters | I | II | III | IV | V |
| Linear equation | y = 1.7418x − 0.0134 | y = 2.6599x − 0.0328 | y = 2.5719x − 0.0266 | y = 1.7827x − 0.0168 | y = 165113x − 26088 | R | 0.9999 | 0.9999 | 0.9998 | 0.9999 | 0.9999 | Linearity range (μg/mL) | 0.10–2.03 | 0.10–2.03 | 0.10–2.03 | 0.10–2.03 | 0.34–27.31 ng/mL | LOD (μg/mL) | 0.005 | 0.005 | 0.005 | 0.005 | 0.05 ng/mL | LOQ (μg/mL) | 0.01 | 0.01 | 0.01 | 0.01 | 0.17 ng/mL | Precision (%) (n = 6) | 0.75 | 1.08 | 0.42 | 1.05 | 0.36 | Repeatability (%) (n = 6) | 3.65 | 3.36 | 2.25 | 5.22 | 8.72 | Stability (%) | 2.10 | 4.04 | 1.53 | 2.55 | 0.57 | Accuracy at low level (n = 3) | Recovery (%) | 102.99 | 101.96 | 104.80 | 100.98 | 91.18 | RSD (%) | 3.09 | 3.09 | 3.64 | 2.30 | 1.89 | Accuracy at medium level (n = 3) | Recovery (%) | 102.68 | 98.35 | 104.20 | 101.69 | 111.27 | RSD (%) | 3.69 | 0.70 | 1.83 | 1.78 | 0.58 | Accuracy at high level (n = 3) | Recovery (%) | 102.53 | 100.84 | 105.78 | 103.28 | 102.96 | RSD (%) | 2.28 | 1.89 | 1.93 | 1.83 | 0.73 |
|
|